Peptide products offered by our office are not approved by the U
That evidence gap makes the delivery method choice more consequential than for most peptides
GLP-1 medications and structured medical weight loss are appropriate for adults with: BMI of 30 or higher, OR BMI of 27+ with at least one weight-related condition (diabetes, prediabetes, hypertension, sleep apnea, fatty liver) Type 2 diabetes (Ozempic, Mounjaro, Trulicity) Documented difficulty losing weight through lifestyle alone Our weight loss program is built for long-term results, not crash outcomes: GLP-1 receptor agonists: semaglutide (Wegovy), liraglutide (Saxenda) Dual GIP/GLP-1 agonists: tirzepatide (Zepbound, Mounjaro) Other FDA-approved weight loss medications when appropriate An honest discussion of medication options and costs up front Nutrition guidance focused on protein and muscle preservation Lab monitoring and side effect management A realistic plan for staying off the medication eventually, or staying on safely 03 Why a primary care provider matters GLP-1 medications affect blood sugar, blood pressure, kidney function, and gallbladder health, interact with other medications, and have side effects that need active management
Sukkar today to schedule a consultation, visit DrSukkar.com to learn more, or call us directly at (281) 940-1535
Ozempic contains semaglutide and is approved for the treatment of type 2 diabetes
Mochi also offers insurance support for patients pursuing brand-name options like Wegovy or Zepbound
